Stereo Drugs Private Limited - Company Profile

It is a pharma private limited company based in Rangareddy, Telangana, India, established in 2008.
2008 Rangareddy, Telangana, India Active
Last Updated:
Access Report
About Stereo Drugs Private Limited

Stereo Drugs Private Limited, a active private limited company, was established on 06 June 2008 in Rangareddy, Telangana, India. Engaging in pharmaceutical retailers & distributors within the manufacturing sector, it holds CIN: U24233TG2008PTC059539. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹3.00 Cr and a paid-up capital of ₹3.00 Cr.

It upholds a compliant status. Its leadership includes Prathima Arveti (Director), Akkisani (Managing Director). Past directors included Anand Srinivas Katta, Kinthada Vijaya Lakshmi, Kinthada Suryanarayana. It holds no open charges and ₹17.06 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2024. It is based at Plot No.165/P, Aparna Palm Groves, Ground Floor, Phase-1, Kompally, Medchal Dist, Telangana, Rangareddy, Telangana, 500100.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24233TG2008PTC059539

  • Registration Number

    059539

  • Incorporation Date

    06 June 2008

  • Authorized Capital

    ₹3.00 Cr

  • Paid-Up Capital

    ₹3.00 Cr

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 3.00 Cr
  • Paid Up Capital ₹ 3.00 Cr
  • Company Age 17 Year, 8 Months
  • Last Filing with ROC 31 Mar 2024
  • Satisfied Charges ₹ 17.06 Cr
  • Revenue Growth **** -41.27%
  • Profit Growth **** 147.77%
  • Ebitda **** -67.13%
  • Net Worth 0.39%
  • Total Assets -8.25%
Company report

Stereo Drugs Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Stereo Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Stereo Drugs Private Limited?
Current Directors
Name Designation Appointment Date Status
Prathima Arveti Director 17 Aug 2023 Current
Akkisani Managing Director 01 Dec 2022 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 22 Aug 2023 Past
Pramod Abcsdd Director 01 Dec 2022 Past
Pramod Abcsdd Managing Director 10 Jun 2022 Past
Pramod Abcsdd Director 31 Jul 2014 Past
Pramod Abcsdd Director 26 Mar 2009 Past
Pramod Abcsdd Director 18 Dec 2009 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Stereo Drugs.

Stereo Drugs Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 41.27% decrease. The company also saw a substantial improvement in profitability, with a 147.77% increase in profit. The company's net worth moved up by a moderate rise of 0.39%.

Stereo Drugs revenue growth over time
Stereo Drugs profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -41.27%
*******
*******
*******
*******
Revenue from Operations
*******
 -41.48%
*******
*******
*******
*******
Total Assets
*******
 -8.25%
*******
*******
*******
*******
Profit or Loss
*******
 147.77%
*******
*******
*******
*******
Net Worth
*******
 0.39%
*******
*******
*******
*******
EBITDA
*******
 -67.13%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Stereo Drugs?

In 2023, Stereo Drugs had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹0

Satisfied Charges

₹170,567,000.00

Charges Breakdown by Lending Institutions
  • Axis Bank Limited : 11.91 Cr
  • Corporation Bank : 5.14 Cr
Latest Charge Details
Date Lender Amount Status
17 Feb 2014 Axis Bank Limited ₹0.54 M Satisfied
31 Oct 2013 Axis Bank Limited ₹11.86 Cr Satisfied
22 Aug 2011 Corporation Bank ₹5.14 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Stereo Drugs?

Stereo Drugs has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Stereo Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Stereo Drugs's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Stereo Drugs
Recent Activity within the Organization
  • Annual General Meeting

    The activity Stereo Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Balance Sheet

    The activity Stereo Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was completed.

  • Director Appointment

    Progress on Prathima Arveti was appointed as a Director was appointed as a Director on 17 Aug 2023 & has been associated with this company since 2 years 6 months . was documented.

  • Director Appointment

    The activity Akkisani was appointed as a Managing Director was appointed as a Managing Director on 01 Dec 2022 & has been associated with this company since 3 years 2 months . was completed.

  • Charges

    A charge registered on 31 Oct 2013 via Charge ID 10459599 with Axis Bank Limited was fully satisfied on 05 May 2022. was recorded as a recent event.

  • Charges

    The activity A charge registered on 17 Feb 2014 via Charge ID 10483075 with Axis Bank Limited was fully satisfied on 02 May 2022. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Stereo Drugs Private Limited?

The CIN of Stereo Drugs Private Limited is U24233TG2008PTC059539.

Where is Stereo Drugs Private Limited headquartered?

Stereo Drugs Private Limited is headquartered at Plot No.165/P, Aparna Palm Groves, Ground Floor, Phase-1, Kompally, Medchal Dist, Telangana, Rangareddy, Telangana, 500100.

When was Stereo Drugs Private Limited incorporated?

Stereo Drugs Private Limited was incorporated on 06 June 2008.

Who are the current directors of Stereo Drugs Private Limited?

The current directors of Stereo Drugs Private Limited are

What is the primary industry of Stereo Drugs Private Limited?

The primary industry of Stereo Drugs Private Limited is Manufacturing.

Is Stereo Drugs Private Limited a listed company?

Stereo Drugs Private Limited is unlisted.

What is the capital structure of Stereo Drugs Private Limited?

The authorized capital of Stereo Drugs Private Limited is ₹3.00 Cr, and the paid-up capital is ₹3.00 Cr.

What is the compliance status of Stereo Drugs Private Limited?

The compliance status of Stereo Drugs Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available